Virological, immune and host genetics markers in the control of HIV infection

被引:0
作者
Mothe, Beatriz [1 ,2 ]
Ibarrondo, Javier [1 ,2 ]
Llano, Anuska [1 ,2 ]
Brander, Christian [1 ,2 ,3 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst HIVACAT, Badalona 08916, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] ICREA, Barcelona, Spain
关键词
HIV-1; long-term non-progressors (LTNP); Elite Controllers (EC); Highly exposed persistently seronegatives (HEPS); CCR5; CTL; Innate immunity; HIV control; immune correlates; HLA allele frequency; HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC-T-LYMPHOCYTE; LONG-TERM SURVIVORS; CLASS-I MOLECULES; CELL RESPONSES; DISEASE PROGRESSION; HLA-B; PROMOTER POLYMORPHISM; VIRAL LOAD; CHEMOKINE RECEPTORS;
D O I
10.1155/2009/360362
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
HIV infection, if left untreated, leads in most cases to the development of wide immune deterioration, opportunistic infections and eventually AIDS and death. The identification of individuals who despite persisting infection show no or few signs of HIV disease progression has spurred hopes that an effective HIV vaccine could be attainable. The design of such a vaccine will greatly depend on the precise definition of disease markers, host genetic and immune characteristics that mediate relative in vivo control of this virus. Accordingly, a number of viral factors and host genetic characteristics have been shown to play a crucial role in the control of HIV disease by delaying progression to AIDS or even preventing infection. There is also an improved understanding of humoral and cellular immune responses in terms of specificity, functional repertoire, longevity and tissue distribution and their ability to contain HIV replication. However, the definition of good immune correlates unequivocally and causally associated with protection or disease progression remains elusive. Here we review work on viral factors, host genetic markers and immunological determinants that have been identified in individuals with superior control of HIV infection or in subjects who remain uninfected despite frequent exposure to the viral pathogen.
引用
收藏
页码:105 / 120
页数:16
相关论文
共 148 条
[101]  
Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845
[102]  
MIURA T, 2000, J VIROL
[103]   Genetic characterization of human immunodeficiency virus type 1 in elite controllers: Lack of gross genetic defects or common amino acid changes [J].
Miura, Toshiyuki ;
Brockman, Mark A. ;
Brumme, Chanson J. ;
Brumme, Zabrina L. ;
Carlson, Jonathan M. ;
Pereyra, Florencia ;
Trocha, Alicja ;
Addo, Marylyn M. ;
Block, Brian L. ;
Rothchild, Alissa C. ;
Baker, Brett M. ;
Flynn, Theresa ;
Schneidewind, Arne ;
Li, Bin ;
Wang, Yaoyu E. ;
Heckerman, David ;
Allen, Todd M. ;
Walker, Bruce D. .
JOURNAL OF VIROLOGY, 2008, 82 (17) :8422-8430
[104]   Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors [J].
Montefiori, DC ;
Pantaleo, G ;
Fink, LM ;
Zhou, JT ;
Zhou, JY ;
Bilska, M ;
Miralles, GD ;
Fauci, AS .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :60-67
[105]   Lymphocyte traffic control by chemokines [J].
Moser, B ;
Loetscher, P .
NATURE IMMUNOLOGY, 2001, 2 (02) :123-128
[106]   Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression:: the protection varies with duration of infection [J].
Mulherin, SA ;
O'Brien, TR ;
Ioannidis, JPA ;
Goedert, JJ ;
Buchbinder, SP ;
Coutinho, RA ;
Jamieson, BD ;
Meyer, L ;
Michael, NL ;
Pantaleo, G ;
Rizzardi, GP ;
Schuitemaker, H ;
Sheppard, HW ;
Theodorou, ID ;
Vlahov, D ;
Rosenberg, PS .
AIDS, 2003, 17 (03) :377-387
[107]   GENETIC AND SEROLOGICAL HETEROGENEITY OF THE SUPERTYPIC HLA-B LOCUS SPECIFICITIES BW4 AND BW6 [J].
MULLER, CA ;
ENGLERBLUM, G ;
GEKELER, V ;
STEIERT, I ;
WEISS, E ;
SCHMIDT, H .
IMMUNOGENETICS, 1989, 30 (03) :200-207
[108]  
Nagasawa T, 2001, ANN NY ACAD SCI, V947, P112
[109]  
Nagasawa T, 2001, ANN NY ACAD SCI, V947, P115
[110]  
Ndongala ML., 2009, Clin Immunol